MV

Mark Velleca

CEO at Black Diamond Therapeutics

Cambridge, Massachusetts

Overview

Work Experience

BD

Black Diamond Therapeutics

  • CEO, Board Chair

    2023 - Current

  • Board Chair

    2022

  • Board Director

    2021 - 2022

MT

Myeloid Therapeutics

  • Executive Chair

    2023

GT

G1 Therapeutics, Inc.

  • Senior Advisor, Board Director

    2021 - 2023

HV

Hatteras Venture Partners

  • Venture Partner

    2021 - 2023

SI

StrideBio, Inc

  • Advisor, CEO, Board Director

    2021 - 2023

GT

G1 Therapeutics, Inc.

  • CEO, Board Director

    2014 - 2020

YU

Yale University School of Medicine

  • Assistant Clinical Professor (adjunct)

    1999 - 2017

  • Associate Research Scientist

    1997 - 1999

TL

The Leukemia & Lymphoma Society

  • Chief Policy and Advocacy Officer

    2012 - 2014

GS

Gilead Sciences

  • Senior Advisor

    2010 - 2012

CP

CGI Pharmaceuticals, Inc.

  • Founder and SVP

    1999 - 2010

    Gilead acquired CGI in 2010

Education

Relevant Websites